Most Recent
Fertility clinic Monash IVF says there are "serious questions" about whether a class action that accuses it of destroying viable embryos was validly commenced as a class action.
For two and a half years, law firm Baker McKenzie represented a client in class action litigation over allegedly defective pelvic mesh products that did not exist, a court has heard.
The rejection of a $27 million settlement offer in a class action over American Medical Systems' pelvic mesh products may be included in a proposed opt out notice, with a judge mulling whether to inform group members about a little used law which allows one lead applicant to take over from another.
Pharmacy giant Priceline is the target of an "imminent" class action, with a group of dissatisfied franchisees accusing the company of exercising an "overly prescriptive" level of control over its franchises and fettering profitability.
The former chief financial officer of delisted Traditional Therapy Clinics has appeared in court after pleading guilty to market manipulation charges relating to transactions intended to create an artificial share price for the traditional therapy clinic company.
A judge has refused to disqualify herself from hearing a complex medical negligence lawsuit after she described an expert conclave as a "car crash", citing concerns over a psychiatrist giving opinions about liability in a surgical setting.
COVID-19 vaccinations will begin this week, but most employers won't be able to force staff to get the jab.
Fertility clinic IVF Australia is facing a lawsuit worth "many millions of dollars" launched by the parents of a child born with Pallister-Kilian syndrome, alleging it did not carry out a vital pre-implantation diagnostic test that would have identified the disease.
Pharmaceutical companies Sanofi and Bristol-Myers Squibb are liable for losses to the federal government for excess subsidies it allegedly paid for the blood-thinner Plavix after an unjustified court injunction prevented the release of a generic version of the top-selling drug, an appeals court has heard.
A $37.75 million settlement has been reached in a shareholder class action against Estia Health that accused the aged care provider of failing to disclose difficulties in its 2015 and 2016 acquisition strategy.